148 related articles for article (PubMed ID: 32763386)
41. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
[TBL] [Abstract][Full Text] [Related]
42. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
43. Doxorubicin-loaded Fe
Cheng C; Li C; Zhu X; Han W; Li J; Lv Y
J Biomater Appl; 2019 May; 33(10):1373-1381. PubMed ID: 30880566
[TBL] [Abstract][Full Text] [Related]
44. Magnetic Fe
Cai W; Zhang W; Chen Z
Colloids Surf B Biointerfaces; 2023 Mar; 223():113170. PubMed ID: 36696823
[TBL] [Abstract][Full Text] [Related]
45. Targeted Delivery of 5-Fluorouracil and Sonidegib via Surface-Modified ZIF-8 MOFs for Effective Basal Cell Carcinoma Therapy.
Padya BS; Fernandes G; Hegde S; Kulkarni S; Pandey A; Deshpande PB; Ahmad SF; Upadhya D; Mutalik S
Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004573
[TBL] [Abstract][Full Text] [Related]
46. Hyaluronic acid nanogels prepared via ortho ester linkages show pH-triggered behavior, enhanced penetration and antitumor efficacy in 3-D tumor spheroids.
Yang G; Fu S; Yao W; Wang X; Zha Q; Tang R
J Colloid Interface Sci; 2017 Oct; 504():25-38. PubMed ID: 28527297
[TBL] [Abstract][Full Text] [Related]
47. A dual-targeting Fe
Liu X; Wang C; Wang X; Tian C; Shen Y; Zhu M
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111455. PubMed ID: 33255040
[TBL] [Abstract][Full Text] [Related]
48. HA targeted-biodegradable nanocomposites responsive to endogenous and exogenous stimulation for multimodal imaging and chemo-/photothermal therapy.
Wang HY; Zhang Y; Ren XH; He XW; Li WY; Zhang YK
Nanoscale; 2021 Jan; 13(2):886-900. PubMed ID: 33367454
[TBL] [Abstract][Full Text] [Related]
49. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
50. Double-Cross-Linked Hyaluronic Acid Nanoparticles with pH/Reduction Dual-Responsive Triggered Release and pH-Modulated Fluorescence for Folate-Receptor-Mediated Targeting Visualized Chemotherapy.
Zhao X; Jia X; Liu L; Zeng J; Tian K; Zhou T; Liu P
Biomacromolecules; 2016 Apr; 17(4):1496-505. PubMed ID: 27010934
[TBL] [Abstract][Full Text] [Related]
51. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors.
Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582
[TBL] [Abstract][Full Text] [Related]
52. Synthesis of stimuli-responsive chitosan nanocomposites via RAFT copolymerization for doxorubicin delivery.
Hosseinzadeh S; Hosseinzadeh H; Pashaei S; Khodaparast Z
Int J Biol Macromol; 2019 Jan; 121():677-685. PubMed ID: 30339997
[TBL] [Abstract][Full Text] [Related]
53. A protein-sulfosalicylic acid/boswellic acids @metal-organic framework nanocomposite as anticancer drug delivery system.
Özsoy M; Atiroğlu V; Guney Eskiler G; Atiroğlu A; Deveci Ozkan A; Özacar M
Colloids Surf B Biointerfaces; 2021 Aug; 204():111788. PubMed ID: 33932885
[TBL] [Abstract][Full Text] [Related]
54. Host-guest fabrication of dual-responsive hyaluronic acid/mesoporous silica nanoparticle based drug delivery system for targeted cancer therapy.
Lu J; Luo B; Chen Z; Yuan Y; Kuang Y; Wan L; Yao L; Chen X; Jiang B; Liu J; Li C
Int J Biol Macromol; 2020 Mar; 146():363-373. PubMed ID: 31911174
[TBL] [Abstract][Full Text] [Related]
55. pH-responsive and self-targeting assembly from hyaluronic acid-based conjugate toward all-in-one chemo-photodynamic therapy.
Wu J; Hu X; Liu R; Zhang J; Song A; Luan Y
J Colloid Interface Sci; 2019 Jul; 547():30-39. PubMed ID: 30933691
[TBL] [Abstract][Full Text] [Related]
56. A pH-Responsive Hydrogel Based on a Tumor-Targeting Mesoporous Silica Nanocomposite for Sustained Cancer Labeling and Therapy.
Chen X; Liu Z
Macromol Rapid Commun; 2016 Sep; 37(18):1533-9. PubMed ID: 27448182
[TBL] [Abstract][Full Text] [Related]
57. Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy.
Ding L; Lin X; Lin Z; Wu Y; Liu X; Liu J; Wu M; Zhang X; Zeng Y
ACS Appl Mater Interfaces; 2020 Aug; 12(33):36906-36916. PubMed ID: 32706242
[TBL] [Abstract][Full Text] [Related]
58. Microfluidic-Assisted ZIF-Silk-Polydopamine Nanoparticles as Promising Drug Carriers for Breast Cancer Therapy.
Gao Z; Mansor MH; Winder N; Demiral S; Maclnnes J; Zhao X; Muthana M
Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37513998
[TBL] [Abstract][Full Text] [Related]
59. Postsynthetic Modification of ZIF-90 for Potential Targeted Codelivery of Two Anticancer Drugs.
Zhang FM; Dong H; Zhang X; Sun XJ; Liu M; Yang DD; Liu X; Wei JZ
ACS Appl Mater Interfaces; 2017 Aug; 9(32):27332-27337. PubMed ID: 28745483
[TBL] [Abstract][Full Text] [Related]
60. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
